Asia-Pacific accounts for 34.8% of the global generics market value

by Sameer Joshi or 25-Jan-2016

Publisher's Generic Drugs industry profile series provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). Each profile contains descriptions of the leading players in the pharmaceuticals industry including key financial metrics and analysis of competitive pressures within the market. Essential resource for indepth data and analysis covering the Global/Country generic drugs market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights from the Global Generics Report

Market value
- The global generics market grew by 9.1% in 2015 to reach a value of $271.2 billion. In 2020, the global generics market is forecast to have a value of $412.9 billion, an increase of 52.3% since 2015.

Market volume - The global generics market grew by 2% in 2015 to reach a volume of 82.2% of total pharma volume. In 2020, the global generics market is forecast to have a volume of 88.7% of total pharma volume, an increase of 7.9% since 2015.

Reports by Country

Generics in Australia
Generics in Brazil
Generics in Canada
Generics in China
Generics in France
Generics in Germany
Generics in India
Generics in Indonesia
Generics in Italy
Generics in Japan
Generics in Mexico
Generics in the Netherlands
Generics in Russia
Generics in Scandinavia
Generics in Singapore
Generics in South Korea
Generics in Spain
Generics in Turkey


Regional Reports

Generics in Asia-Pacific
Generics in Europe
Generics in North America
Generics in South Africa
Generics in the United Kingdom
Generics in the United States
Global Generics

 Key Questions Answered





What was the size of the generic drugs market by value in 2015?

What will be the size of the generic drugs market in 2020?

What factors are affecting the strength of competition in the generic drugs market?

How has the market performed over the last five years?

How large is the global’s generics market in relation to its regional counterparts?